2023 Approvals
FDA Approves JESDUVROQ for Anemia in Chronic Kidney Disease Patients on Dialysis on February 1, 2023
What is JESDUVROQ prescribed for? To treat anemia caused by chronic kidney disease for adults on dialysis for at least four months. What is the name of the drug and what does it do? JESDUVROQ (generic name: daprodustat), pronounced “jez–DOOV–rok,” is a type of medicine that helps people